Melanie Myers is a motivated, results-driven Lead Clinical Research Associate with 21+ years of clinical research experience spanning multiple therapeutic areas including Metabolic Disorders, Oncology, Pediatric CNS, Pediatric Pain Management, Phase I, Ophthalmology, Dermatology, and Respiratory. She has 16+ years of global clinical operations leadership in the CRO environment across all aspects of clinical trials encompassing Phase I – IIIb.
Melanie has strong leadership and interpersonal skills, with an outstanding record of establishing positive relationships. Her industry experience includes roles as a Study Coordinator, CRA, Sr. CRA, Lead CRA, Sr. Clinical Trials Manager and Senior Clinical Team Lead. In her most recent role as Sr. CTL, she served as the Clinical Lead of a Phase II NASH clinical trial. She has recent rescue experience of a Phase II NASH program and assisted in leading the team to successful completion of the study and achieving deliverables in advance of scheduled timelines.
During her 16-year Clinical Management career, Melanie has provided clinical management oversight and successful delivery of numerous Phase I – IIIb programs in Non-Alcoholic Steatohepatitis (NASH) with Type II Diabetes, Hematologic Malignancies: T-Cell Lymphoma, B-Cell Lymphoma, Chronic Myelogenous Leukemia, and Mantle Cell Lymphoma, Solid Tumor, Adult End Stage – First in Man, Prostate Cancer, Age-related macular degeneration (AMD), Pediatric End Stage Oncology, Pediatric Pain Management, Pediatric Petit-Mal Epilepsy, Pediatric Psoriasis, Acne, Aesthetics and corrective, Psoriasis, Asthma, and Seasonal allergic rhinitis.